Bio-Techne (TECH) Other Operating Expenses (2009 - 2014)

Bio-Techne's (TECH) quarterly Other Operating Expenses came in at -$2.4 million in Q3 2014, down 345.49% year-on-year from $965421.1 in Q3 2013, and down 345.49% quarter-over-quarter from -$532000.0 in Q3 2013.

Bio-Techne (TECH) Other Operating Expenses (2009 - 2014) Analysis & Trends

Bio-Techne's Other Operating Expenses history runs 4 years deep, the most recent figure standing at -$2.4 million for Q3 2014.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn
7 Belite Bio 61.40 Bn 61.40 Bn -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn
9 Revolution Medicines 37.37 Bn 37.37 Bn -
10 Bio-Techne 11.19 Bn 10.98 Bn 208.29 Mn

Historic Data

Download Data
DateValue
Sep 30, 2014 -2.37 Mn
Sep 30, 2013 -532,000.00
Jun 30, 2010 -720,000.00
Mar 31, 2010 240,000.00
Dec 31, 2009 240,000.00
Sep 30, 2009 240,000.00